Latest Strategy Changes News

Metal Powder Works has achieved a key validation milestone for its commercially pure titanium powder, confirming performance on par with industry benchmarks for cold spray applications. This breakthrough positions MPW to expand into the lucrative aerospace and advanced manufacturing markets.

Activeport Group launches Asia’s inaugural software-orchestrated Network-to-Network Interconnect Exchange in Singapore, integrating Megaport’s global data centre connectivity to transform cross-border telecom services.

Genesis Minerals has more than doubled its FY26 exploration budget to A$40-50 million, driven by promising drilling results at its Leonora and Laverton gold assets. Recent assays reinforce the company’s strategy of organic growth supported by resource expansion near existing processing infrastructure.

High-Tech Metals has secured a binding mining agreement with SSH Mining to advance the high-grade Wagtail Gold Deposit, enabling near-term production with minimal capital risk.

Critica Limited has greenlit a pilot beneficiation plant in Hanoi to upscale its rare earth concentrate production, aiming to validate significant mass rejection and grade uplift ahead of its Scoping Study.

Cyclone Metals has launched a comprehensive Pre-Feasibility Study for its Iron Bear iron ore project in Canada, aiming to refine development plans and attract global steel market demand.

RooLife Group Ltd reported a sharp 51% revenue decline to $4.62 million and a 31% increase in net loss to $2.76 million for FY2025, as it pivots towards higher-margin sectors including renewable energy and global social commerce.

PT Aneka Tambang Tbk (ANTAM) reported a remarkable 240% surge in net profit for the half year ended June 30, 2025, driven by robust gold and nickel sales amid a challenging mining sector.

Opthea Limited reported a 26% reduction in net loss for FY2025 despite discontinuing its wet AMD drug after failed Phase III trials. The company settled its Development Funding Agreement with investors, securing liquidity and planning a strategic pivot.

Botanix Pharmaceuticals posted a sharp revenue increase driven by its new hyperhidrosis treatment Sofdra, yet reported a substantial net loss reflecting heavy investment in commercialisation. The company’s strong cash position underpins its path to profitability.

Merino & Co. Limited reported a significant 36% decline in revenues alongside a $2.76 million loss for the fiscal year ended June 2025, marking a stark reversal from the prior year’s modest profit.

Holista Colltech reports a sharp 70% reduction in net loss and an 8.6% revenue rise, driven by strong supplements sales and a landmark collagen partnership with Regenerex Pharma.